Skip to content
10-Q

Quarterly Report

Rapport Therapeutics, Inc. RAPP

0000950170-25-104565

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 36.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 35.44M sh
Shares Diluted Q2 2025 · Jun 30, 2025 35.36M sh
Shares Diluted Q2 2025 · Jun 30, 2024 10.67M sh
Shares Diluted Q2 2025 · Jun 30, 2024 6.36M sh
Capex Q2 2025 · Jun 30, 2025 $313K
Capex Q2 2025 · Jun 30, 2024 $2.04M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$45.31M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$33.97M
Short Term Investments Q2 2025 · Jun 30, 2025 $205.38M
Short Term Investments Q2 2025 · Dec 31, 2024 $248.48M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $55.07M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $56.81M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $110.16M
Stockholders Equity Q2 2025 · Jun 30, 2025 $263.51M
Stockholders Equity Q2 2025 · Mar 31, 2025 $285.84M
Stockholders Equity Q2 2025 · Dec 31, 2024 $305.43M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 −$336.89M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$39.63M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$25.63M
Current Liabilities Q2 2025 · Jun 30, 2025 $11.88M
Current Liabilities Q2 2025 · Dec 31, 2024 $8.77M
Total Liabilities Q2 2025 · Jun 30, 2025 $21.98M
Total Liabilities Q2 2025 · Dec 31, 2024 $9.51M
Current Assets Q2 2025 · Jun 30, 2025 $270.24M
Current Assets Q2 2025 · Dec 31, 2024 $309.8M
Total Assets Q2 2025 · Jun 30, 2025 $285.5M
Total Assets Q2 2025 · Dec 31, 2024 $314.93M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.75
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.44
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.70
Eps Diluted Q2 2025 · Jun 30, 2024 −$6.42
Eps Basic Q2 2025 · Jun 30, 2025 −$0.75
Eps Basic Q2 2025 · Jun 30, 2025 −$1.44
Eps Basic Q2 2025 · Jun 30, 2024 −$1.70
Eps Basic Q2 2025 · Jun 30, 2024 −$6.42
Rd Expense Q2 2025 · Jun 30, 2025 $22.68M
Rd Expense Q2 2025 · Jun 30, 2025 $42.25M
Rd Expense Q2 2025 · Jun 30, 2024 $15.69M
Rd Expense Q2 2025 · Jun 30, 2024 $28.19M
Net Income Q2 2025 · Jun 30, 2025 −$26.73M
Net Income Q2 2025 · Jun 30, 2025 −$50.8M
Net Income Q2 2025 · Mar 31, 2025 −$24.06M
Net Income Q2 2025 · Dec 31, 2024 −$78.3M
Net Income Q2 2025 · Jun 30, 2024 −$18.12M
Net Income Q2 2025 · Jun 30, 2024 −$40.79M
Net Income Q2 2025 · Mar 31, 2024 −$22.67M
Operating Income Q2 2025 · Jun 30, 2025 −$29.5M
Operating Income Q2 2025 · Jun 30, 2025 −$56.6M
Operating Income Q2 2025 · Jun 30, 2024 −$20.8M
Operating Income Q2 2025 · Jun 30, 2024 −$37.89M